References
- American Cancer Society (2010).The global economic cost of cancer: Atlanta, Georgia, USA.
- American Cancer Society (2008). Global cancer facts & figures. Atlanta, GA: USA.
- Ammar W (2003) Health system and reform in Lebanon. Lebanon: Ministry of Public Health.
- Complete the reference of The Guardian to become: "The Guardian (2012). Healthcare spending around the world, country by country. www.theguardian.com/news/datablog/interactive/2012/jun/30/health-spending-map-world"
- Elkin EB, Bach PB (2010). Cancer's next frontier: addressing high and increasing costs. JAMA, 303, 1086-7. https://doi.org/10.1001/jama.2010.283
- Experts in Chronic Myeloid Leukemia (ECML) (2013). The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts. Blood 121, 4439-42. https://doi.org/10.1182/blood-2013-03-490003
- Himmelstein DU, Thorne D, Warren E, Woolhandler S (2009). Medical bankruptcy in the United States, 2007: results of a national study. Am J Med, 122, 741-6. https://doi.org/10.1016/j.amjmed.2009.04.012
- Himmelstein DU, Woolhandler S (2012). Cost control in a parallel universe: medicare spending in the United States and Canada. Arch Intern Med, 172, 1764-6. https://doi.org/10.1001/2013.jamainternmed.272
- International Medical Statistics (IMS) (2014). Available at: www.imshealth.com/en/about-us/news/ims-health-study:-cancerdrug-innovation-surges-as-cost-growth-moderates.
- Kantarjian HM, Fojo T, Mathisen M, Zwelling LA. (2013). Cancer drugs in the United States: Justum Pretium-the just price. J Clin Oncol, 31, 3600-4. https://doi.org/10.1200/JCO.2013.49.1845
- Lee CP, Chertow GM, Zenios SA (2009). An empiric estimate of the value of life: updating the renal dialysis costeffectiveness standard. Value Health, 12, 80-7. https://doi.org/10.1111/j.1524-4733.2008.00401.x
- Luengo-Fernandez R, Leal J, Gray A, Sullivan R (2013). Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncol, 14, 1165-74. https://doi.org/10.1016/S1470-2045(13)70442-X
- Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML (2011). Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst, 103, 117-28. https://doi.org/10.1093/jnci/djq495
- Murray CJ, Kreuser J, Whang W (1994). Cost-effectiveness analysis and policy choices: investing in health systems. Bull World Health Organ, 72, 663-74.
- National Cancer Registry (2008). MOPH. Available at: http://www.moph.gov.lb/Prevention/Surveillance/Pages/Cancer.aspx
- National Cancer Treatment Guidelines (2012). MOPH.
- National Health Accounts (2012). MOPH.
- Newcomer LN, Gould B, Page RD, Donelan SA, Perkins M (2014). Changing physician incentives for affordable, quality cancer care: results of an episode payment model. J Oncol Pract, 10, 322-6. https://doi.org/10.1200/JOP.2014.001488
- The Guardian (2012). Healthcare spending around the world, country by country.
- World Bank (WB) (2015). Health expenditure, total (% of GDP) .
- World Health Report (2010). World Health Organization, Geneva, Swtizerland.
- Yabroff KR, Lamont EB, Mariotto A, et al. (2008). Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst, 100, 630-41. https://doi.org/10.1093/jnci/djn103
- Yabroff KR, Lund J, Kepka D, Mariotto A (2011). Economic burden of cancer in the United States: estimates, projections, and future research. Cancer Epidemiol Biomarkers Prev, 20, 2006-14. https://doi.org/10.1158/1055-9965.EPI-11-0650
- Zullig LL, Peppercorn JM, Schrag D, et al (2013). Financial distress, use of cost-coping strategies, and adherence to prescription medication among patients with cancer. J Oncol Pract, 9, 60-3. https://doi.org/10.1200/JOP.2013.000971